BioAge Labs, Inc.

NasdaqGS:BIOA Stock Report

Market Cap: US$686.1m

BioAge Labs Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BIOA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Oct 24BuyUS$4,329,019Andreessen Horowitz LLCCompany219,195US$19.90
27 Sep 24BuyUS$7,200,000Longitude Capital Management Co., LLCCompany400,000US$18.00
27 Sep 24BuyUS$10,800,018Sofinnova Investment, Inc.Company600,001US$18.00
27 Sep 24BuyUS$16,200,000Andreessen Horowitz LLCCompany900,000US$18.00
27 Sep 24BuyUS$1,199,952Synergy Capital LimitedCompany66,664US$18.00
27 Sep 24BuyUS$8,100,000Cormorant Asset Management, LPCompany450,000US$18.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BIOA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies758,4392.12%
Individual Insiders1,299,6893.63%
General Public7,767,76521.7%
VC/PE Firms9,547,36226.6%
Institutions16,475,48346%

Dilution of Shares: BIOA only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 71.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.02%
Andreessen Horowitz LLC
3,233,170US$61.9m7.27%0.7%
6.43%
Sofinnova Investment, Inc.
2,304,901US$44.1m0%3.56%
6.17%
RA Capital Management, L.P.
2,210,589US$42.3m0%0.51%
5.02%
Khosla Ventures, LLC
1,798,702US$34.4m0%1.94%
4.77%
Longitude Capital Management Co., LLC
1,710,589US$32.7m0%5.65%
4.55%
Cormorant Asset Management, LP
1,629,529US$31.2m0%1.46%
4.06%
Suvretta Capital Management, LLC
1,455,000US$27.8m0%1.0%
3.97%
OrbiMed Advisors LLC
1,423,470US$27.2m0%0.37%
3.38%
Kristen Fortney
1,210,056US$23.2m0%no data
3.16%
Horsley Bridge Partners LLC
1,132,590US$21.7m0%no data
3.03%
Sands Capital Ventures, LLC
1,086,353US$20.8m0%5.14%
2.77%
AllianceBernstein L.P.
994,315US$19.0m0%0.01%
2.19%
RTW Investments, LP
786,353US$15.1m0%0.2%
2.12%
Kaiser Permanente Group Trust
758,439US$14.5m0%no data
1.47%
Pivotal BioVenture Partners LLC
527,647US$10.1m0%3.84%
1.42%
Emerald Advisers, LLC
510,748US$9.8m0%0.2%
1.25%
T. Rowe Price Group, Inc.
449,837US$8.6m0%no data
1.07%
Redpoint Management, LLC
383,255US$7.3m0%0.77%
1.06%
Kaiser Foundation Health Plan Inc., Endowment Arm
379,219US$7.3m0%100.0%
0.93%
Brown Advisory Incorporated
334,915US$6.4m0%0.01%
0.84%
Artal Group S.A.
300,000US$5.7m0%0.15%
0.76%
Comprehensive Financial Management LLC
271,842US$5.2m0%0.13%
0.71%
Wasatch Advisors LP
254,907US$4.9m0%0.02%
0.6%
Citadel Advisors LLC
213,718US$4.1m0%no data
0.56%
Marshall Wace LLP
200,000US$3.8m0%0.01%